Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

FOXO

FOXO Technologies (FOXO)

FOXO Technologies Inc
De:
Trier par:
 Showing the most relevant articles for your search:AMEX:FOXO
DateHeureSourceTitreSymboleSociété
09/05/202417h04Edgar (US Regulatory)Form 8-K - Current reportAMEX:FOXOFOXO Technologies Inc
23/04/202423h00GlobeNewswire Inc.FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing RequirementsAMEX:FOXOFOXO Technologies Inc
14/02/202415h32GlobeNewswire Inc.FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i GlobalAMEX:FOXOFOXO Technologies Inc
25/01/202423h00Business WireFOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of DirectorsAMEX:FOXOFOXO Technologies Inc
22/01/202414h30Business WireFOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness SolutionsAMEX:FOXOFOXO Technologies Inc
19/12/202314h30Business WireFOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing RequirementsAMEX:FOXOFOXO Technologies Inc
01/12/202315h01Business WireFOXO Technologies On Track to Commence Commercial Rollout of VITHAR™ AI Health Coach in Early 2024AMEX:FOXOFOXO Technologies Inc
29/11/202322h30Business WireFOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-QAMEX:FOXOFOXO Technologies Inc
10/11/202314h30Business WireFOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR™ AI Health CoachAMEX:FOXOFOXO Technologies Inc
08/11/202315h00Business WireFOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern TimeAMEX:FOXOFOXO Technologies Inc
07/11/202315h23Business WireFOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock SplitAMEX:FOXOFOXO Technologies Inc
30/10/202313h30Business WireFOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Company’s Epigenetic Data with the Power of AIAMEX:FOXOFOXO Technologies Inc
27/10/202323h15Business WireFOXO Technologies Inc. Announces Reverse Stock SplitAMEX:FOXOFOXO Technologies Inc
23/10/202314h00Business WireFOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate StrategyAMEX:FOXOFOXO Technologies Inc
13/10/202314h00Business WireFOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic BiomarkersAMEX:FOXOFOXO Technologies Inc
06/10/202314h30Business WireFOXO Technologies™ Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense ReductionsAMEX:FOXOFOXO Technologies Inc
06/09/202314h30Business WireFOXO Technologies Announces Agreement With Atrio InsuranceAMEX:FOXOFOXO Technologies Inc
31/08/202314h30Business WireFOXO Technologies Inc. Announces NYSE American Acceptance of Compliance PlanAMEX:FOXOFOXO Technologies Inc
18/08/202322h15Business WireFOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE AmericanAMEX:FOXOFOXO Technologies Inc
17/08/202314h30Business WireFOXO Technologies™ Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human LongevityAMEX:FOXOFOXO Technologies Inc
11/08/202316h53Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:FOXOFOXO Technologies Inc
10/08/202323h19Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:FOXOFOXO Technologies Inc
10/08/202322h05Business WireFOXO Technologies™ Announces Second Quarter 2023 Financial ResultsAMEX:FOXOFOXO Technologies Inc
08/08/202323h11Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]AMEX:FOXOFOXO Technologies Inc
08/08/202314h30Business WireFOXO Technologies™ Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CTAMEX:FOXOFOXO Technologies Inc
07/08/202314h30Business WireLongevity Biotech Companies GERO and FOXO Technologies™ to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health TrajectoriesAMEX:FOXOFOXO Technologies Inc
04/08/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessAMEX:FOXOFOXO Technologies Inc
31/07/202323h26Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]AMEX:FOXOFOXO Technologies Inc
28/07/202319h06Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesAMEX:FOXOFOXO Technologies Inc
21/07/202323h21Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:FOXOFOXO Technologies Inc
 Showing the most relevant articles for your search:AMEX:FOXO

Dernières Valeurs Consultées